Advertisement
Antibiotic prescription rates are high in low- and middle-income countries

Antibiotic Prescribing High in Low-, Middle-Income Countries

0
Proportion of patients with inappropriate prescriptions ranged from 8 to 100 percent
Under 17 percent of adults said they smoked in 2014

CDC: Adult Smoking Rate Falls to New Low in the United States

0
As of 2014, rate is 16.8 percent but big socioeconomic disparities remain
There is variation in influenza vaccination coverage by industry and occupation

Variation in Occupational Influenza Vaccination Coverage

0
Wide variation by state in vaccination coverage among tier 1 and health care personnel groups
Physicians say prior authorization continues to interfere with patient care and can lead to adverse clinical consequences

Health Plans Not Implementing Prior Authorization Reforms

0
Findings based on American Medical Association survey of practicing physicians' experiences
When it comes to dealing with illness

Many Americans Turn to ‘Laying on of Hands’ to Promote Healing

0
And, nearly nine out of 10 have asked for divine intervention for someone else
A monthly vaginal ring containing dapivirine can reduce the incidence of HIV-1 infection

Reduced HIV-1 Infection Incidence With Vaginal Ring

0
Monthly vaginal ring containing dapivirine reduces risk of HIV-1 infection among African women
Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels

Trained Alert Dogs Can Detect Impending T1DM-Related Events

0
In study, individual dogs' performance varied for detecting hypoglycemic episodes, hyperglycemia
For childhood cancer survivors

Early Breast Cancer Screening Benefits Childhood Cancer Survivors

0
Early initiation of breast cancer screening with MRI may reduce breast cancer mortality by more than half

Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022

0

Disparities in prevalence observed, with higher odds seen among Hispanic, Asian, and Black individuals

Ibrance (palbociclib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer among postmenopausal women.

FDA Approves Ibrance to Treat Advanced Breast Cancer

0
For postmenopausal women with ER+, HER2− metastatic breast cancer